Pharmacogenetics of antipsychotic-induced weight gain

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Psychopharmacology

• Publication date

  2004-07-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00213-004-1949-9PMID 15243737
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies.

  2004cited by this paper
• Obesity as a risk factor for antipsychotic noncompliance.

  2004cited by this paper
• Pharmacogenetics of psychotropic drug response.

  2004cited by this paper
• Contents of The American Journal of Psychiatry

  2004cited by this paper
• Prader-Willi Syndrome as a Model for Obesity

  2003cited by this paper
• The human obesity gene map: the 2002 update.

  2003cited by this paper
• Effect of acute psychotic stress in nondiabetic subjects on beta-cell function and insulin sensitivity.

  2003cited by this paper
• Plasma leptin, fatty acids, and tumor necrosis factor-receptor and insulin resistance in children.

  2003cited by this paper
• H1-Histamine Receptor Affinity Predicts Short-Term Weight Gain for Typical and Atypical Antipsychotic Drugs

  2003cited by this paper
• Mutations in the adiponectin gene in lean and obese subjects from the Swedish obese subjects cohort.

  2003influential reference
• Obesity risk is associated with carbohydrate intake in women carrying the Gln27Glu beta2-adrenoceptor polymorphism.

  2003cited by this paper
• The glutamine 27 glutamic acid polymorphism of the β2‐adrenoceptor gene is associated with abdominal obesity and greater risk of impaired glucose tolerance in men but not in women: a population‐based study in Spain

  2003cited by this paper
• The Effect of the −308A Allele of the TNF-α Gene on Insulin Action Is Dependent on Obesity

  2003cited by this paper
• The effect of the -308A allele of the TNF-alpha gene on insulin action is dependent on obesity.

  2003influential reference
• &bgr;2 Adrenoceptor Functional Gene Variants, Obesity, and Blood Pressure Level Interactions in the General Population

  2003cited by this paper
• Sequence variants of the POMC gene and their associations with body composition in children.

  2003cited by this paper
• Signals that Control Central Appetite Regulation

  2003cited by this paper
• Monitoring of stored and available fuel by the CNS: implications for obesity

  2003cited by this paper
• Adipocytokines in anorexia nervosa: a review focusing on leptin and adiponectin.

  2003cited by this paper
• Body mass index and quality of life in community-dwelling patients with schizophrenia.

  2003cited by this paper
• Role of obesity and leptin in the pubertal process and pubertal growth—a review

  2003cited by this paper
• Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment.

  2003cited by this paper
• The impact of weight gain on quality of life among persons with schizophrenia.

  2003cited by this paper
• Polymorphism of the promoter region of the serotonin 5-HT(2C) receptor gene and clozapine-induced weight gain.

  2003cited by this paper
• Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients.

  2003cited by this paper
• Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

  2003cited by this paper
• The TNF- α Gene NcoI Polymorphism at Position –308 of the Promoter Influences Insulin Resistance, and Increases Serum Triglycerides after Postprandial Lipaemia in Familiar Obesity

  2003cited by this paper
• Promoter polymorphisms of the TNF-alpha (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study.

  2003influential reference
• The glucocorticoid receptor gene and its association to metabolic syndrome.

  2002cited by this paper
• Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery.

  2002influential reference
• Association studies for quantitative traits in structured populations

  2002cited by this paper
• Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians.

  2002cited by this paper
• A variation in the ghrelin gene increases weight and decreases insulin secretion in tall, obese children.

  2002influential reference
• Dopamine transporter genotype as a risk factor for obesity in African-American smokers.

  2002influential reference
• Pronounced Early Increase in Circulating Leptin Predicts a Lower Weight Gain During Clozapine Treatment

  2002influential reference
• Association of the TNF-alpha -308 G/A promoter polymorphism with insulin resistance in obesity.

  2002influential reference
• Pharmacogenomics in schizophrenia: the quest for individualized therapy.

  2002cited by this paper
• Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism.

  2002cited by this paper
• In vivo alpha(1)-adrenergic lipolytic activity in subcutaneous adipose tissue of obese subjects.

  2002cited by this paper
• Role of ghrelin polymorphisms in obesity based on three different studies.

  2002cited by this paper
• Cytochrome P450 polymorphisms and response to antipsychotic therapy.

  2002cited by this paper
• A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome.

  2002cited by this paper
• Sympathetic Neural Activation in Visceral Obesity

  2002cited by this paper
• Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes.

  2002cited by this paper
• Physical consequences of schizophrenia and its treatment: the metabolic syndrome.

  2002cited by this paper
• The effects of novel antipsychotics on glucose and lipid levels.

  2002cited by this paper
• Low dose leptin administration reverses effects of sustained weight-reduction on energy expenditure and circulating concentrations of thyroid hormones.

  2002cited by this paper
• Genetic variant of the histamine-1 receptor (glu349asp) and body weight change during clozapine treatment

  2002cited by this paper
• Investigation of promoter variants of the histamine 1 and 2 receptors in schizophrenia and clozapine response.

  2002cited by this paper
• -759C/T genetic variation of 5HT(2C) receptor and clozapine-induced weight gain.

  2002cited by this paper
• A Polymorphism in the Leptin Promoter Region (-2548 G/A) Influences Gene Expression and Adipose Tissue Secretion of Leptin

  2002influential reference
• Increased visceral fat distribution in drug-naive and drug-free patients with schizophrenia

  2002cited by this paper
• Cytochrome P450 Phenotyping/Genotyping in Patients Receiving Antipsychotics

  2002cited by this paper
• 759C/T genetic variation of 5HT(2C) receptor and clozapine-induced weight gain.

  2002cited by this paper
• In Vivo α1-Adrenergic Lipolytic Activity in Subcutaneous Adipose Tissue of Obese Subjects

  2002cited by this paper
• −759C/genetic variation of 5HT2C receptor and clozapine-induced weight gain

  2002cited by this paper
• Pharmacogenetics of Psychotropic Drugs

  2002cited by this paper
• Association of the TNF-α−308 G/A Promoter Polymorphism with Insulin Resistance in Obesity

  2002cited by this paper
• Initial sequencing and analysis of the human genome

  2001cited by this paper
• Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin.

  2001cited by this paper
• Glucocorticoid receptor Bcl I variant is associated with an increased atherogenic profile in response to long-term overfeeding.

  2001influential reference
• The peripheral sympathetic nervous system in human obesity

  2001cited by this paper
• RAPID COMMUNICATIONS: Mutations in the Preproghrelin/Ghrelin Gene Associated with Obesity in Humans

  2001influential reference
• Tumor necrosis factor-alpha--308 G/A polymorphism in obese Caucasians.

  2001influential reference
• Central infusion of histamine reduces fat accumulation and upregulates UCP family in leptin-resistant obese mice.

  2001cited by this paper
• Tumor necrosis factor-α−308 G/A polymorphism in obese Caucasians

  2001cited by this paper
• Broad therapeutic uses of atypical antipsychotic medications.

  2001cited by this paper
• A role for ghrelin in the central regulation of feeding

  2001cited by this paper
• High-throughput genotyping with single nucleotide polymorphisms.

  2001cited by this paper
• New onset diabetes and atypical antipsychotics.

  2001cited by this paper
• Antipsychotic Metabolic Effects: Weight Gain, Diabetes Mellitus, and Lipid Abnormalities

  2001cited by this paper
• Targeted disruption of histamine H1-receptor attenuates regulatory effects of leptin on feeding, adiposity, and UCP family in mice.

  2001cited by this paper
• Genotype Arg/Arg, but not Trp/Arg, of the Trp64Arg polymorphism of the beta(3)-adrenergic receptor is associated with type 2 diabetes and obesity in a large Japanese sample.

  2001cited by this paper
• Relationship of the Trp64Arg polymorphism of the beta3-adrenoceptor gene to central adiposity and high blood pressure: interaction with age. Cross-sectional and longitudinal findings of the Olivetti Prospective Heart Study

  2001cited by this paper
• Atypical antipsychotics and hyperglycaemia

  2001cited by this paper
• Molecular screening of the proopiomelanocortin (POMC ) gene in Italian obese children: report of three new mutations

  2001influential reference
• Interactions among the glucocorticoid receptor, lipoprotein lipase and adrenergic receptor genes and abdominal fat in the Québec Family Study

  2001influential reference
• A Ser311Cys mutation in the human dopamine receptor D2 gene is associated with reduced energy expenditure.

  2001cited by this paper
• Extrapyramidal side effects are unacceptable.

  2001cited by this paper
• Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle.

  2001influential reference
• Effect of amantadine on weight gain during olanzapine treatment.

  2001cited by this paper
• Pharmacogenomics and schizophrenia: clinical implications

  2001cited by this paper
• The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

  2001cited by this paper
• The pharmacology of weight gain with antipsychotics.

  2001cited by this paper
• Beta-2 adrenergic receptor variants are associated with subcutaneous fat accumulation in response to long-term overfeeding

  2001influential reference
• The N363S polymorphism of the glucocorticoid receptor: potential contribution to central obesity in men and lack of association with other risk factors for coronary heart disease and diabetes mellitus.

  2001cited by this paper
• The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome.

  2001cited by this paper
• Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study.

  2000cited by this paper
• Modulation of blood pressure and obesity with the dopamine D2 receptor gene TaqI polymorphism.

  2000cited by this paper
• Identification of polymorphic loci in the promoter region of the serotonin 5-HT2C receptor gene and their association with obesity and Type II diabetes

  2000cited by this paper
• Role of tumor necrosis factor-alpha gene locus in obesity and obesity-associated hypertension in French Canadians.

  2000cited by this paper
• Overweight, obesity, and health risk.

  2000cited by this paper
• Association of Trp64Arg polymorphism of the β3-adrenergic receptor gene and no association of Gln223Arg polymorphism of the leptin receptor gene in Japanese schoolchildren with obesity

  2000cited by this paper
• Dopaminergic Agonists Normalize Elevated Hypothalamic Neuropeptide Y and Corticotropin-Releasing Hormone, Body Weight Gain, and Hyperglycemia in ob/ob Mice

  2000cited by this paper
• Obesity and cortisol.

  2000cited by this paper
• Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24.

  2000cited by this paper
• Elevated levels of insulin, leptin, and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses.

  2000cited by this paper
• The histamine 1 and histamine 2 receptor genes - candidates for schizophrenia and clozapine drug response

  2000cited by this paper
• Effects of Antidepressants on Weight and on the Plasma Levels of Leptin, TNF-α and Soluble TNF Receptors: A Longitudinal Study in Patients Treated with Amitriptyline or Paroxetine

  2000cited by this paper
• Susceptible locus for obese type 2 diabetes mellitus in the 5'-flanking region of the tumor necrosis factor-alpha gene.

  2000cited by this paper

• Clinical and molecular implications of antipsychotics in MASLD.

  2025cites this paper
• Total antioxidant capacity, obesity and clinical correlates in first-episode and drug-naïve patients with schizophrenia.

  2023cites this paper
• Obesity, antioxidants and negative symptom improvement in first-episode schizophrenia patients treated with risperidone

  2023cites this paper
• Patterns and Determinants of Weight Gain among People Who Use Drugs Undergoing Treatment for Recovery in Lebanon

  2023cites this paper
• CYP2D6 Genetic Variation and Antipsychotic-Induced Weight Gain: A Systematic Review and Meta-Analysis

  2022cites this paper
• Nutritional parameters and lifestyle practices of people who use drugs undergoing treatment for recovery in Lebanon: a descriptive study

  2021cites this paper
• Metabolic events associated with the use of antipsychotics in children, adolescents and young adults: a multinational sequence symmetry study

  2020cites this paper
• Progress in Genetic Polymorphisms Related to Lipid Disturbances Induced by Atypical Antipsychotic Drugs

  2020cites this paper
• Leptin Serum Levels are Associated With GLP-1 Receptor Agonist-Mediated Effects on Glucose Metabolism in Clozapine- or Olanzapine-Treated, Prediabetic, Schizophrenia Patients

  2020cites this paper
• NDT_A_208061 2087..2099

  2019cites this paper
• Pharmacogenetic Correlates of Antipsychotic-Induced Weight Gain in the Chinese Population

  2019cites this paper
• Atypical antipsychotics-induced metabolic syndrome and nonalcoholic fatty liver disease: a critical review

  2019cites this paper
• Associations between the LEP -2548G/A promoter and baseline weight and between LEPR Gln223Arg and Lys656Asn variants and change in BMI z in Arab children and adolescents treated with risperidone

  2018cites this paper
• Modulation of the Plasma Ghrelin Level by Intraventromedial Hypothalamic Microinjection of D2 Receptors Agonist and Antagonist

  2018cites this paper
• Drug-induced hyperglycaemia and diabetes: pharmacogenomics perspectives

  2018cites this paper
• Associations between the LEP -2548G/A Promoter and Baseline Weight and between LEPR Gln223Arg and Lys656Asn Variants and Change in BMI z Scores in Arab Children and Adolescents Treated with Risperidone

  2018cites this paper
• Effect of Psychopharmacotherapy on Body Mass Index Among Children and Adolescents with Bipolar Disorders

  2017cites this paper
• The predictive value of ABCB1, ABCG2, CYP3A4/5 and CYP2D6 polymorphisms for risperidone and aripiprazole plasma concentrations and the occurrence of adverse drug reactions

  2017cites this paper
• The importance of gene-environment interactions in human obesity.

  2016cites this paper
• A systematic review of genetic variants associated with metabolic syndrome in patients with schizophrenia.

  2016cites this paper
• Severe Mental Illnesses and Metabolic Syndrome: The Need for More Awareness and Better Care

  2016cites this paper
• A systematic review and meta-analysis of randomised controlled trials of treatments for clozapine-induced obesity and metabolic syndrome

  2016cites this paper
• Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis.

  2016cites this paper
• Effects of risperidone treatment on the expression of hypothalamic neuropeptide in appetite regulation in Wistar rats.

  2015cites this paper
• Antipsychotics-induced metabolic alterations: focus on adipose tissue and molecular mechanisms.

  2015cites this paper
• Possible association between DBH 19 bp insertion/deletion polymorphism and clinical symptoms in schizophrenia with tardive dyskinesia

  2015cites this paper
• Impact of HSD11B1 polymorphisms on BMI and components of the metabolic syndrome in patients receiving psychotropic treatments

  2015cites this paper
• Leptin receptor and ghrelin genes polymorphisms in relation to the metabolism of lipids

  2015cites this paper
• Pathophysiological mechanisms of increased cardiometabolic risk in people with schizophrenia and other severe mental illnesses.

  2015cites this paper
• Quetiapine Effect against Increased Body Weight on Schizophrenic Patients

  2015cites this paper
• HTR2C polymorphisms, olanzapine-induced weight gain and antipsychotic-induced metabolic syndrome in schizophrenia patients: A meta-analysis

  2014cites this paper
• The effects of olanzapine on genome-wide DNA methylation in the hippocampus and cerebellum

  2014cites this paper
• Polymorphisms of the leptin and HTR2C genes and clozapine-induced weight change and baseline BMI in patients with chronic schizophrenia

  2014cites this paper
• Aus der Klinik für Psychiatrie und Psychotherapie

  2014cites this paper
• Antipsychotic Induced Weight Gain: Genetics, Epigenetics, and Biomarkers Reviewed

  2014cites this paper
• The relationship between obesity and health-related quality of life in Chinese patients with schizophrenia

  2013cites this paper
• Weight Gain in Risperidone Therapy: Investigation of Peripheral Hypothalamic Neurohormone Levels in Psychotic Patients

  2013cites this paper
• Allostatic Load as a Tool for Monitoring Physiological Dysregulations and Comorbidities in Patients with Severe Mental Illnesses

  2013cites this paper
• Influence of CRTC1 polymorphisms on body mass index and fat mass in psychiatric patients and the general adult population.

  2013cites this paper
• Association of the dopamine β‐hydroxylase 19 bp insertion/deletion polymorphism with positive symptoms but not tardive dyskinesia in schizophrenia

  2013cites this paper
• Pharmacogenetics of antipsychotics: recent progress and methodological issues

  2013cites this paper
• The relationship between obesity and neurocognitive function in Chinese patients with schizophrenia

  2013cites this paper
• ESTUDIO MULTIDISCIPLINAR DE SEGUIMIENTO DEL PESO CORPORAL EN UNA COHORTE DE PACIENTES EN TRATAMIENTO INICIAL CON ANTIPSICÓTICOS MULTIDISCIPLINARY FOLLOW-UP STUDY OF BODY WEIGHT IN A COHORT OF PATIENTS WITH ONSET OF ANTIPSYCHOTIC TREATMENT

  2013cites this paper
• Genetics of schizophrenia: What do we know?

  2013cites this paper
• The investigation of leptin and hypothalamic neuropeptides role in first attack psychotic male patients: olanzapine monotherapy.

  2013cites this paper
• Leptin reduces food intake via a dopamine D2 receptor-dependent mechanism.

  2012cites this paper
• Metabolic and Cardiovascular Adverse Effects Associated with Treatment with Antipsychotic Drugs

  2012cites this paper
• Association between Ghrelin gene (GHRL) polymorphisms and clinical response to atypical antipsychotic drugs in Han Chinese schizophrenia patients

  2012cites this paper
• Using Medication to Manage Behaviour Problems among Adults with Intellecual Disability: Section 4 Guide to Using Psychotropic Medication to Manage Behaviour Problems among Adults with Intellectual Disability Technical Document

  2012cites this paper
• Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications

  2012cites this paper
• ADRA 1 A gene is associated with BMI in chronic schizophrenia patients exposed to antipsychotics

  2012cites this paper
• Pharmacogenomic associations with weight gain in olanzapine treatment of patients without schizophrenia.

  2012cites this paper
• Prediction of long-term metabolic effects of olanzapine and risperidone treatment from baseline body mass index in schizophrenia and bipolar disorder.

  2011cites this paper
• A transdisciplinary perspective of chronic stress in relation to psychopathology throughout life span development

  2011cites this paper
• Weight Gain and Changes in Metabolic Variables following Olanzapine Treatment in Schizophrenia and Bipolar Disorder

  2011cites this paper
• Toward understanding genetic risk for differential antipsychotic response in individuals with schizophrenia

  2011cites this paper
• The prevalence of metabolic syndrome in Korean patients with schizophrenia receiving a monotherapy with aripiprazole, olanzapine or risperidone.

  2011cites this paper
• Antipsychotic drugs and obesity.

  2011cites this paper
• A polymorphism and weight gain in patients with schizophrenia nder long-term clozapine , risperidone or olanzapine treatment

  2011cites this paper
• Weight Gain and Metabolic Syndrome Among Young Patients on Antipsychotic Medication: What do we Know and Where do we go?

  2011cites this paper
• Efficacy of quetiapine in treatment of behavioral disorders in adolescents

  2011cites this paper
• Why Research On the Pharmacogenetics of Atypical Antipsychotic-Induced Weight Gain in Individuals With Intellectual Disabilities Is Warranted

  2011cites this paper
• Étude clinique et pharmacogénétique sur la réponse et les effets secondaires des médicaments psychotropes

  2011cites this paper
• Switching among Antipsychotics in Everyday Clinical Practice: Focus on Ziprasidone

  2011cites this paper
• Risperidone long-acting injectable in recent-onset schizophrenia examined with clinician and patient self-report measures.

  2010influential citation
• Genetic association between TNF‐α −308 G>A polymorphism and longitudinal weight change during clozapine treatment

  2010cites this paper
• Association study of polymorphisms in Insulin Induced Gene 2 (INSIG2) with antipsychotic‐induced weight gain in European and African‐American schizophrenia patients

  2010cites this paper
• Effectiveness of Medications Used to Attenuate Antipsychotic-Related Weight Gain and Metabolic Abnormalities: A Systematic Review and Meta-Analysis

  2010cites this paper
• Metabolic Effect of Atypical Antipsychotics: How Bad It Can Be?

  2010cites this paper
• Increased serum S100B in never-medicated and medicated schizophrenic patients.

  2010cites this paper
• Body weight gain induced by atypical antipsychotics: an extension of the monocygotic twin and sib pair study

  2010cites this paper
• Frequencies of Polymorphisms in Cytokines, Neurotransmitters and Adrenergic Receptors in Patients With Complex Regional Pain Syndrome Type I After Distal Radial Fracture

  2010cites this paper
• Management of antipsychotic-related weight gain

  2010cites this paper
• Treatment implications of the schizophrenia prodrome.

  2010cites this paper
• ADRA1A gene is associated with BMI in chronic schizophrenia patients exposed to antipsychotics

  2010cites this paper
• The International Consortium on Lithium Genetics (ConLiGen): an initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment.

  2010cites this paper
• Neuronal histamine and its receptors: implication of the pharmacological treatment of obesity.

  2010cites this paper
• Association Study of Energy Homeostasis Genes and Antipsychotic-Induced Weight Gain in Patients with Schizophrenia

  2010cites this paper
• Olanzapine compared to quetiapine in adolescents with a first psychotic episode

  2009cites this paper
• Risperidone Treatment Increases CB1 Receptor Binding in Rat Brain

  2009cites this paper
• Antipsychotics in children and adolescents: increasing use, evidence for efficacy and safety concerns.

  2009cites this paper
• The need for individualised antipsychotic drug therapy in patients with schizophrenia.

  2009cites this paper
• Polymorphisms of the LEP- and LEPR Gene and Obesity in Patients Using Antipsychotic Medication

  2009cites this paper
• The moderating impact of ethnicity on metabolic outcomes during treatment with olanzapine and aripiprazole in patients with schizophrenia.

  2009cites this paper
• Farmacogenética da esquizofrenia

  2009cites this paper
• Management of clozapine–induced weight gain

  2008cites this paper
• Impact of Obesity on Health‐related Quality of Life in Schizophrenia and Bipolar Disorder

  2008cites this paper
• An investigation of the α1A‐adrenergic receptor gene and antipsychotic‐induced side‐effects

  2008cites this paper
• SNAP-25 gene polymorphisms and weight gain in schizophrenic patients.

  2008cites this paper
• Measurement of problem behaviour during medication evaluations.

  2008cites this paper
• Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy

  2008cites this paper
• Effect of Antipsychotics on Peptides Involved in Energy Balance in Drug-Naive Psychotic Patients After 1 Year of Treatment

  2008cites this paper
• Antipsychotic Induced Weight Gain in Schizophrenia: Mechanisms and Management

  2008cites this paper
• UNIVERSITATIS UPSALIENSIS UPPSALA 2008 Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 335 Pharmacogenetics and Antipsychotic Treatment in Schizophrenia with Special Focus on Adverse Drug Reactions

  2008cites this paper
• Insulin sensitivity, adjusted beta-cell function and adiponectinaemia among lean drug-naive schizophrenic patients treated with atypical antipsychotic drugs: a nine-month prospective study.

  2008cites this paper
• Möglichkeiten des Gewichtsmanagements in der Behandlung schizophrener Psychosen mit atypischen Antipsychotika

  2008cites this paper
• Child and adolescent schizophrenia: pharmacological approaches

  2008cites this paper
• Physical health in schizophrenia and related disorders

  2008cites this paper
• Association of antipsychotic induced weight gain and body mass index with GNB3 gene: a meta-analysis.

  2008cites this paper
• Schizofrenie en antipsychotica: Samenhang met het metabool syndroom

  2008cites this paper